Skip to content

dr. Brouwers Barbara

Oncologie
contactgegevens curriculum vitae
09/01/2020
Oncologie

The added value of geriatric assessment in evaluating a patient’s Health-Related Quality-of-Life: A study in ≥70-year-old early-stage invasive breast cancer patients.

Eur J Cancer Care (Engl). 2020 Sep;29(5):e13278. doi: 10.1111/ecc.13278. Epub 2020 Jun 18.PMID: 32557904dr. Brouwers Barbara
06/12/2023
Oncologie

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.

Clin Cancer Res. 2019 Mar 15;25(6):1766-1773. doi: 10.1158/1078-0432.CCR-18-1943. Epub 2018 Sep 12.PMID: 30209161dr. Brouwers Barbara
05/01/2018
Oncologie

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12.PMID: 29431193dr. Brouwers Barbara
06/12/2023
Oncologie

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Genome Med. 2018 Nov 21;10(1):85. doi: 10.1186/s13073-018-0595-5.PMID: 30458854dr. Brouwers Barbara
03/01/2018
Oncologie

The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.

J Geriatr Oncol. 2018 Mar;9(2):152-162. doi: 10.1016/j.jgo.2017.10.001. Epub 2017 Nov 20.PMID: 29167064dr. Brouwers Barbara
06/01/2022
Oncologie

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.

J Geriatr Oncol. 2022 Jun;13(5):582-593. doi: 10.1016/j.jgo.2022.01.009. Epub 2022 Jan 31.PMID: 35101364dr. Brouwers Barbara
06/12/2023
Oncologie

Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study.

Transl Oncol. 2022 Nov;25:101527. doi: 10.1016/j.tranon.2022.101527. Epub 2022 Sep 3.PMID: 36067542dr. Brouwers Barbara
05/01/2018
Oncologisch Centrum

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12. PMID: 29431193dr. Brouwers Barbaradr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
06/12/2023
Oncologie

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9. PMID:dr. Brouwers Barbara
11/01/2018
Oncologie

Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival.

J Geriatr Oncol. 2018 Nov;9(6):606-612. doi: 10.1016/j.jgo.2018.03.021. Epub 2018 Apr 21. PMID: 29685380dr. Brouwers Barbara
06/12/2023
Oncologie

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.

BMC Cancer. 2018 Oct 22;18(1):1014. doi: 10.1186/s12885-018-4920-6.dr. Brouwers Barbara
Oncologie

Immunotherapie.

Kortrijk2022-11-22dr. Brouwers Barbara
Oncologie

Uro-oncologie.

Oostkamp2022-10-20dr. Brouwers Barbara
Oncologie

Post ASCO-ESMO.

West-Vlaanderen2022-09-27dr. Brouwers Barbara
Oncologie

Immune Related Adverse Events of Immuun checkpoint inhibition.

Brugge2022-02-24dr. Brouwers Barbara
Oncologie

Symposium Electronische Communicatie.

Brugge2022-03-08dr. Brouwers Barbara
Oncologie

Het geriatrisch assessment bij borst- en pelviene tumoren.

Edegemdr. Brouwers Barbara
Oncologie

Immunotherapie in het gemetastaseerd blaascarcinoma.

Bruggedr. Brouwers Barbara
Oncologie

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.

dr. Brouwers Barbara